SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001041062-24-000040
Filing Date
2024-02-12
Accepted
2024-02-12 13:38:22
Documents
1
Group Members
BRANDES INVESTMENT PARTNERS, L.P.BRANDES WORLDWIDE HOLDINGS, L.P.CO-GP, LLCGLENN CARLSON

Document Format Files

Seq Description Document Type Size
1 13G Eagle_Pharmaceuticals.txt SC 13G 11429
  Complete submission text file 0001041062-24-000040.txt   13495
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Subject) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88022 | Film No.: 24618941
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 4275 EXECUTIVE SQUARE 5TH FLOOR LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE 5TH FLOOR LA JOLLA CA 92037 8587550239
BRANDES INVESTMENT PARTNERS, LP (Filed by) CIK: 0001015079 (see all company filings)

IRS No.: 330704072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G